Gemcitabine
10mM in DMSO
- Product Code: 190296
CAS:
95058-81-4
| Molecular Weight: | 263.20 g./mol | Molecular Formula: | C₉H₁₁F₂N₃O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00869720 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Gemcitabine is primarily used as an anticancer agent in the treatment of various solid tumors. It is commonly prescribed for non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer. The drug functions by interfering with DNA synthesis, thereby inhibiting cancer cell proliferation.
It is often used in combination with other chemotherapy agents. For example, in pancreatic cancer, it is frequently administered with cisplatin or albumin-bound paclitaxel. In non-small cell lung cancer, it is combined with platinum-based drugs like carboplatin.
Gemcitabine is administered intravenously and is valued for its ability to improve survival rates and reduce tumor size in certain cancers, particularly in advanced stages. It is also used in palliative care to help manage symptoms and improve quality of life.
Due to its mechanism of action, it can cause side effects such as myelosuppression, fatigue, nausea, and liver enzyme elevations, requiring careful monitoring during treatment.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿1,290.00 |
+
-
|
Gemcitabine
Gemcitabine is primarily used as an anticancer agent in the treatment of various solid tumors. It is commonly prescribed for non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer. The drug functions by interfering with DNA synthesis, thereby inhibiting cancer cell proliferation.
It is often used in combination with other chemotherapy agents. For example, in pancreatic cancer, it is frequently administered with cisplatin or albumin-bound paclitaxel. In non-small cell lung cancer, it is combined with platinum-based drugs like carboplatin.
Gemcitabine is administered intravenously and is valued for its ability to improve survival rates and reduce tumor size in certain cancers, particularly in advanced stages. It is also used in palliative care to help manage symptoms and improve quality of life.
Due to its mechanism of action, it can cause side effects such as myelosuppression, fatigue, nausea, and liver enzyme elevations, requiring careful monitoring during treatment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :